Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer

Author(s):
Kroon, J.; Puhr, M.; Buijs, J.T.; Horst, G. van der (0000-0003-1696-160X); Hemmer, D.M.; Marijt, K.A.; Hwang, M.S.; Masood, M.; Grimm, S.; Storm, G.; Metselaar, J.M.; Meijer, O.C. (0000-0002-8394-6859); Culig, Z.; Pluijm, G. van der (0000-0002-1351-1884)
Published
2016
Publication type
Article / Letter to editor
docetaxelglucocorticoid receptorprostate cancertherapy resistance
Date issued
2016-01-31
Language
English
Is part of
Endocrine-Related Cancer (2016), Vol. 23, no. 1, p. 35-45
hdl
1887/108077
doi
10.1530/ERC-15-0343